Patents by Inventor Ben Dake

Ben Dake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240325390
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: November 23, 2021
    Publication date: October 3, 2024
    Applicant: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240130966
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: February 15, 2022
    Publication date: April 25, 2024
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240108622
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 6, 2023
    Publication date: April 4, 2024
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240041879
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 11, 2023
    Publication date: February 8, 2024
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11813263
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: November 14, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11806349
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: November 7, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20230086230
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: August 15, 2022
    Publication date: March 23, 2023
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20230056721
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 11, 2022
    Publication date: February 23, 2023
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11464776
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: October 11, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11413289
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: August 16, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20220218706
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 14, 2022
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20220184080
    Abstract: The invention relates to nebulized imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: March 3, 2022
    Publication date: June 16, 2022
    Inventor: Ben Dake
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11298355
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 12, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11229650
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 25, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200375895
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: December 3, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360377
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE FORMULATIONS FOR KINASE INHIBITION
    Publication number: 20200360477
    Abstract: The invention relates to inhalable formulations configured to inhibit target combinations of kinases for the treatment of cardiovascular and pulmonary diseases such as pulmonary arterial hypertension (PAH).
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventor: Ben Dake
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360275
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF
    Publication number: 20200360277
    Abstract: The invention generally relates to inhalable formulations of imatinib, imatinib metabolites, imatinib salts, their manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360376
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin